In 1988, Peter Doherty joined St. Jude Children's Research Hospital in Memphis, Tennessee as the Chair of the Department of Immunology, which he retained until 2001. Doherty's research focused on the
immune system and his Nobel Prize-winning work described how the body's immune cells protect against viruses. He and Rolf Zinkernagel, the co-recipient of the 1996 Nobel Prize in Physiology or Medicine, discovered how
T cells recognise their target antigens in combination with
major histocompatibility complex (MHC) proteins. Viruses infect host cells and reproduce inside them. Killer T-cells destroy those infected cells so that the viruses cannot reproduce. In landmark mouse studies of lymphocytic-choriomeningitis virus (LCMV),
Rolf Zinkernagel and Doherty demonstrated that a T cell recognises an infected target only when it simultaneously detects (i) a viral peptide antigen and (ii) a self-specific molecule of the major histocompatibility complex class I (MHC I) displayed on the target-cell surface. This recognition was done by a T-cell receptor on the surface of the T cell. The MHC was previously identified as being responsible for the rejection of incompatible tissues during transplantation. Zinkernagel and Doherty discovered that the MHC was responsible for the body fighting
meningitis viruses too. ==Awards and honours==